Author tools & resources | Elsevier
Whatever stage you are at in your publication journey, Elsevier has resources to make your tasks easier.
Related Articles
Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR
Results of the EA4151/BMT-CTN 1601 trial showed similar progression-free and overall outcomes with the addition of autologous transplant to rituximab in mantle cell lymphoma.
What is the Whipple procedure? Explaining Randy Moss’ cancer surgery
Pancreatic cancer survival rates have more than doubled in the past decade. It’s not because of a single breakthrough, but better knowledge of the cancer,…
Axi-Cel Sustains Long-Term Efficacy in R/R Follicular Lymphoma and MZL
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The year in cancer: 24 advances in 2024
By W. Kimryn Rathmell Director, National Cancer Institute Dr.
AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants
$50,000 over one year for researchers that seek to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast  The editors of Blood are pleased to introduce a podcast series, published weekly…
Lisaftoclax Plus Pd Yields High ORRs and Shows Encouraging Safety Profile in RRMM
The BCL-2 inhibitor lisaftoclax was well tolerated and produced encouraging responses in relapsed/refractory multiple myeloma when given in combination with Pd.
3 Things You Should Know About Hemolytic Anemias
Hemolytic anemias are a collection of rare but severe diseases including paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Registration | Society of Gynecologic Oncology
The SGO Annual Meeting on Women’s Cancer® is the premier educational and scientific event for professionals dedicated to advancing gynecologic cancer care. It brings together…
Exploring a New Generation of Patient-Centric Cancer Clinical Trials
Register for Exploring a New Generation of Patient-Centric Cancer Clinical Trials, a virtual patient advocacy event hosted by the AACR.